Human Genome Centre, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia.
Cancer Epidemiol. 2013 Oct;37(5):634-8. doi: 10.1016/j.canep.2013.05.007. Epub 2013 Jun 24.
To investigate the allele and genotype frequencies of NFKB1 -94 ins/del ATTG (rs28720239) polymorphism and to evaluate the association between the polymorphism and colorectal cancer (CRC) risk in Malaysian population.
Genomic DNA was extracted from the peripheral blood samples of 474 study subjects, which consisted of 237 histopathologically confirmed CRC patients and an equal number of cancer-free controls. The NFKB1 -94 ins/del ATTG (rs28720239) polymorphism was genotyped using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method and confirmed by DNA sequencing. The association between the polymorphic genotypes and CRC risk was evaluated by deriving odds ratios (ORs) and 95% confidence intervals (CIs) using unconditional logistic regression analysis.
The frequencies of wildtype (del/del), heterozygous (del/ins) and variant (ins/ins) genotypes in CRC patients were 31.7%, 53.6% and 14.8%, respectively, while those in cancer-free controls were 35.0%, 58.2% and 6.8%, respectively. The frequency of the variant genotype was significantly higher in cases compared to controls (P<0.01). Evaluation of the risk association of the polymorphic genotypes revealed that the variant genotype could contribute to a significantly increased risk of CRC (OR=2.42, 95% CI=1.24-4.73, P<0.01).
The variant allele of NFKB1 -94 ins/del ATTG (rs28362491) polymorphism is associated with higher risk of sporadic CRC in Malaysian population.
研究 NFKB1-94ins/delATTT(rs28720239) 多态性的等位基因和基因型频率,并评估该多态性与马来西亚人群结直肠癌(CRC)风险之间的关联。
从 474 例研究对象的外周血样本中提取基因组 DNA,其中包括 237 例经组织病理学证实的 CRC 患者和数量相等的无癌对照。使用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法对 NFKB1-94ins/delATTT(rs28720239) 多态性进行基因分型,并通过 DNA 测序进行确认。使用非条件逻辑回归分析得出优势比(ORs)和 95%置信区间(CIs),以评估多态基因型与 CRC 风险之间的关联。
CRC 患者中野生型(del/del)、杂合型(del/ins)和变异型(ins/ins)基因型的频率分别为 31.7%、53.6%和 14.8%,而无癌对照组的频率分别为 35.0%、58.2%和 6.8%。与对照组相比,病例组中变异型基因型的频率显著更高(P<0.01)。对多态基因型的风险关联进行评估显示,变异基因型可能导致 CRC 的风险显著增加(OR=2.42,95%CI=1.24-4.73,P<0.01)。
NFKB1-94ins/delATTT(rs28362491) 多态性的变异等位基因与马来西亚人群散发性 CRC 的风险增加相关。